![Valérie Calenda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Valérie Calenda
Directeur/Membre du Conseil chez
keepMED Ltd.
Profil
Valérie Calenda is currently a Director at keepMED Ltd., Keranova SA, Physio-Assist SAS, Mablink Bioscience SAS, and Amyl Therapeutics SRL.
She is also the Managing Partner at Mérieux Equity Partners SAS since 2010.
Previously, she was a Director at Proclara Biosciences, Inc. and VALKEE Oy.
From 1994 to 2000, she was the Director of Business Development at Transgene, Inc. She was also a Director at ImaginAb, Inc. and a Principal at both the University of California, Davis and the Institut National de la Santé & de la Recherche Médicale.
Dr. Calenda received her undergraduate and doctorate degrees from the University of Marseille.
Postes actifs de Valérie Calenda
| Sociétés | Poste | Début |
|---|---|---|
Mérieux Equity Partners SAS
 Mérieux Equity Partners SAS Investment ManagersFinance Mérieux Equity Partners (MxEP) invests in small and mid-size companies located in Europe and North. The firm focuses on healthcare, nutrition and life sciences sectors. It participates in early stages capital requirements and growth capital transactions. The firm acquires either minority or majority stakes in its portfolio companies. | Private Equity Investor | 01/01/2010 |
keepMED Ltd.
 keepMED Ltd. Medical SpecialtiesHealth Technology Manufactures innovative devices for treating obstructive sleep apnea | Directeur/Membre du Conseil | - |
Keranova SA
 Keranova SA Medical SpecialtiesHealth Technology Designs and develops surgical equipment for ophthalmologic | Directeur/Membre du Conseil | - |
Amyl Therapeutics SRL
 Amyl Therapeutics SRL BiotechnologyHealth Technology Operates as a preclinical biotechnology company | Directeur/Membre du Conseil | - |
Physio-Assist SAS
 Physio-Assist SAS Medical SpecialtiesHealth Technology Develops and manufactures medical equipment | Directeur/Membre du Conseil | - |
Mablink Bioscience
 Mablink Bioscience Pharmaceuticals: MajorHealth Technology Manufactures antibody-drug conjugates | Directeur/Membre du Conseil | - |
Anciens postes connus de Valérie Calenda
| Sociétés | Poste | Fin |
|---|---|---|
Transgene, Inc.
 Transgene, Inc. BiotechnologyHealth Technology Founded in 1982, Transgene, Inc. is a clinical-stage biotechnology company specializing in cancer immunotherapy through viral vector engineering. The company is based in Dover, DE. The company develops individualized therapeutic vaccines using its proprietary myvac® platform, which designs personalized vaccines targeting tumor-specific neoantigens to stimulate the patient’s immune system against early-stage solid tumors. Its lead product, TG4050, is an individualized neoantigen vaccine in randomized phase 1/2 trials as an adjuvant treatment for HPV-negative head and neck squamous cell carcinoma. Transgene’s pipeline also includes oncolytic virus candidates BT-001 and TG6050, engineered to express immune-modulating antibodies and cytokines, evaluated in early-phase clinical trials for various solid tumors. | Corporate Officer/Principal | - |
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Research institute | Corporate Officer/Principal | - |
VALKEE Oy
 VALKEE Oy Medical SpecialtiesHealth Technology Develops and manufactures health devices | Directeur/Membre du Conseil | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Valérie Calenda
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Proclara Biosciences, Inc.
 Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Provides treatment of chronic neurodegenerative diseases | Health Technology |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Research institute | Commercial Services |
University of Marseille
 University of Marseille Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mérieux Equity Partners SAS
Mérieux Equity Partners SAS Investment ManagersFinance Mérieux Equity Partners (MxEP) invests in small and mid-size companies located in Europe and North. The firm focuses on healthcare, nutrition and life sciences sectors. It participates in early stages capital requirements and growth capital transactions. The firm acquires either minority or majority stakes in its portfolio companies. | Finance |
VALKEE Oy
VALKEE Oy Medical SpecialtiesHealth Technology Develops and manufactures health devices | Health Technology |
Transgene, Inc.
Transgene, Inc. BiotechnologyHealth Technology Founded in 1982, Transgene, Inc. is a clinical-stage biotechnology company specializing in cancer immunotherapy through viral vector engineering. The company is based in Dover, DE. The company develops individualized therapeutic vaccines using its proprietary myvac® platform, which designs personalized vaccines targeting tumor-specific neoantigens to stimulate the patient’s immune system against early-stage solid tumors. Its lead product, TG4050, is an individualized neoantigen vaccine in randomized phase 1/2 trials as an adjuvant treatment for HPV-negative head and neck squamous cell carcinoma. Transgene’s pipeline also includes oncolytic virus candidates BT-001 and TG6050, engineered to express immune-modulating antibodies and cytokines, evaluated in early-phase clinical trials for various solid tumors. | Health Technology |
ImaginAb, Inc.
 ImaginAb, Inc. Medical SpecialtiesHealth Technology Develops radiopharmaceutical and imaging agent products | Health Technology |
keepMED Ltd.
keepMED Ltd. Medical SpecialtiesHealth Technology Manufactures innovative devices for treating obstructive sleep apnea | Health Technology |
Keranova SA
Keranova SA Medical SpecialtiesHealth Technology Designs and develops surgical equipment for ophthalmologic | Health Technology |
Physio-Assist SAS
Physio-Assist SAS Medical SpecialtiesHealth Technology Develops and manufactures medical equipment | Health Technology |
Mablink Bioscience
Mablink Bioscience Pharmaceuticals: MajorHealth Technology Manufactures antibody-drug conjugates | Health Technology |
Amyl Therapeutics SRL
Amyl Therapeutics SRL BiotechnologyHealth Technology Operates as a preclinical biotechnology company | Health Technology |
